by The global precision medicine market size accounted for USD 102.17 billion in 2024 and is anticipated to attain USD 470.53 billion by 2034, at a CAGR of 16.5%.
Get Sample Copy of Report@ https://www.precedenceresearch.com/sample/1085
Key Takeaways
- The North American market had the highest market share in 2023.
- Asia Pacific is expected to expand rapidly over the forecast period.
- Among technologies, the genomics segment was the market leader in 2023.
- The therapeutics segment accounted for a large portion of the market based on application in 2023.
- The oncology segment dominated the market by indication in 2023.
- The hospitals segment remained the top end-use category in 2023.
Market Dynamics
Drivers
The precision medicine market is primarily driven by advancements in genomics, biotechnology, and artificial intelligence, which are enabling personalized treatment approaches. The increasing prevalence of chronic diseases, particularly cancer, cardiovascular disorders, and neurological conditions, has fueled the demand for targeted therapies. Additionally, rising investments in research and development by pharmaceutical and biotechnology companies, along with government initiatives supporting precision medicine, are contributing to market growth.
Opportunities
The growing integration of big data analytics and machine learning in healthcare presents significant opportunities for precision medicine. The increasing adoption of wearable devices and mobile health applications is further driving demand for personalized treatment strategies. Moreover, the expanding use of biomarkers and companion diagnostics in drug development is expected to create new growth avenues in the market.
Challenges
Despite its potential, precision medicine faces challenges such as high development costs, data privacy concerns, and regulatory complexities. The limited availability of skilled professionals and interoperability issues in integrating genomic data with existing healthcare systems also hinder market growth. Additionally, disparities in access to precision medicine, particularly in low- and middle-income countries, remain a significant challenge.
Regional Insights
North America dominates the precision medicine market, driven by strong research infrastructure, favorable regulatory policies, and the presence of key market players. Asia Pacific is anticipated to grow at the fastest rate due to increasing healthcare investments, advancements in genomics, and rising awareness of personalized medicine. Europe also holds a substantial market share, supported by government initiatives and the growing adoption of precision therapies.
Precision Medicine Market Companies
- Biocrates Life Sciences
- Tepnel Pharma Services
- Novartis
- Qiagen
- Quest Diagnostics
- Menarini Silicon Biosystems
- NanoString Technologies
- Eagle Genomics
- Pfizer
- Intomics
- Roche
- Teva Pharmaceutical
Recent Devlopments
- In January 2024, BIOS Health entered into partnership with the Kern Venture Group to establish a hub for precision medicine in Bakersfield, California, U.S.
Segments Covered in the Report
By Technology
- Bioinformatics
- Big Data Analytics
- Drug Discovery
- Gene Sequencing
- Companion Diagnostics
- Others
By Application
- CNS
- Immunology
- Oncology
- Respiratory
- Others
By End-Use
- Diagnostic Companies
- Pharmaceutical Companies
- Healthcare IT companies
- Others
By Sequencing Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
By Product
- Consumables
- Instruments
- Services
By Route of Administration
- Oral
- Injectable
By Drugs
- Alectinib
- Osimertinib
- Mepolizumab
- Aripiprazole Lauroxil
- Others
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/
